Juvenile idiopathische Arthritis und Uveitis: Screening und antientzündliche Therapie

Arnd Heiligenhaus; Anne Mingels; Ulrich Neudorf; Gerd Ganser

doi:10.1055/s-2003-44613

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2003; 220(11): 738-753
DOI: 10.1055/s-2003-44613

Übersicht

Juvenile idiopathische Arthritis und Uveitis: Screening und antientzündliche Therapie

Juvenile Idiopathic Arthritis and Uveitis: Screening and Anti-Inflammatory TherapyArnd Heiligenhaus¹ , Anne Mingels¹ , Ulrich Neudorf² , Gerd Ganser³

¹Augenabteilung am St.-Franziskus-Hospital, Münster
²Universitätskinderklinik Essen
³St.-Josef-Stift Sendenhorst, Abteilung Kinder- und Jugendrheumatologie

Abstract

Zusammenfassung

In der Übersichtsarbeit werden die entzündlich-rheumatischen Erkrankungen im Kindesalter hinsichtlich Pathogenese, Epidemiologie, Diagnostik und klinischem Verlauf beschrieben. EULAR, ACR und die aktuelle ILAR-Klassifikation werden verglichen und die medikamentöse antientzündliche Therapie dargestellt. Es folgt eine Übersicht über die Uveitis bei den verschiedenen Arthritisformen. Die prognostischen Faktoren für das Auftreten einer Uveitis, der klinische Verlauf, die Komplikationen, die prognostischen Faktoren für Visusverlust sowie die antientzündliche Therapie werden behandelt. Die Empfehlungen der „Uveitis im Kindesalter - Studiengruppe” zu Screeninguntersuchung und Behandlung bei Uveitis bei juveniler idiopathischer Arthritis werden dargelegt und eine bundesweite Dokumentation dieser Patienten beschrieben.

Abstract

This article provides an overview of the rheumatic diseases in childhood, their pathogenesis, epidemiology, diagnosis and clinical course. EULAR, ACR and the current ILAR-classification are compared. The antiinflammatory medical treatment is described. The characteristics of uveitis in the various forms of arthritis are reviewed. The prognostic factors for uveitis manifestation, the clinical course, complications, the prognostic factors for visual loss, and the diverse antiinflammatory medical regimens are evaluated. The suggestions of the „uveitis in childhood study group” concerning screening and treatment of uveitis in patients with juvenile idiopathic arthritis are provided, and a nation-wide documentation of these patients is described.

Schlüsselwörter

Uveitis - juvenile idiopathische Arthritis - Iritis - Iridozyklitis - Immunsuppression

Key words

Uveitis - juvenile idiopathic arthritis - iritis - iridocyclitis - immunsuppression

Full Text

References

Literatur

1 Aasland A, Flato B, Vandvik I H. Psychosocial Outcome in Juvenile Chronic Arthritis: A nine year follow-up. Clin Exp Rheumatol. 1997; 15 (5) 561-568
2 Andersson G are. Juvenile arthritis - who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999; 17 (3) 367-374
3 Bloch-Michel E, Nussenblatt R B. International uveitis study group recommentations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1976; 103 234-235
4 Breit W, Frosch M, Meyer U, Heinecke A, Ganser G. A subgroup specific evaluation of efficacy of triamcinolone-hexacetonide in juvenile chronic arthritis. J Rheumatol. 2000; 27 2696-2702
5 Brewer E J, Bass J, Baum J. et al . Current proposed revision of JRA criteria. JRA Criteria Subcommittee of the diagnostic and therapeutic criteria committee of the american rheumatism section of the arthritis foundation. Arthritis Rheum. 1977; 20 195-199
6 Cassidy J T, Sullivan D B, Petty R E. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1977; 20 224-227
7 Cassidy J T, Petty R E. Textbook of Pediatric Rheumatology, 4^rd Edition, W. B. Saunders Co., Philadelphia American Academy of Pediatrics Section on rheumatology and section on ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993; 92 295-296
8 Cassidy J T, Petty R E. Textbook of Pediatric Rheumatology, 4^rd Edition. Philadelphia; WB Saunders Co 2001
9 Chalom E C, Goldsmith D P, Koehler M A. et al . Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997; 24 2031-2034
10 Chylack L T, Bienfang D C, Bellows A R, Stillmann J S. Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol. 1975; 79 1026-1033
11 Chylack L T. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum. 1977; 20 217-223
12 Cross A G. Uveitis in children. Trans Ophthalmol Soc UK. 1965; 85 409-419
13 Dana M R, Merayo-Lloves J, Schamberg D A, Foster C S. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997; 104 236-244
14 David J, Cooper C, Hickey L, Lloyd J, Dore C, McCullough C, Woo P. The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol. 1994; 33 (9) 876-881
15 Foster C S, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis (see comments). Ophthalmology. 1993; 100 809-817
16 Foster C S, Havrlikova K, Baltatzis S, Christen W G, Merayo-Lloves J. Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand. 2000; 78 576-579
17 Frosch M, Herter B, Ganser G, Roth J, Harms E. Therapie der juvenilen chronischen Arthritis mit Sulfasalazin. Monatschr Kinderheilkd. 1997; 145 724-728
18 Ganser G, Zepp F, Wagner N. Juvenile Rheumatoide Arthritis. In: Schulte, Schaub, Lenze, Spranger (Hrsg) Lehrbuch der Pädiatrie. Berlin, Heidelberg, New York; Springer Verlag 2000: 587-600
19 Ganser G. Physikalische Therapie bei juveniler chronischer Arthritis und Kollagenosen. Akt Rheumatol. 2002; 27 213-220
20 Giannini E H, Malagan C N, Kerckhove C van. et al . Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991; 18 1394-1397
21 Giannini E H, Brewer E J, Kuzmina N. et al . Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double blind, placebo-controlled trial. N Engl J Med. 1992; 326 1043-1049
22 Giordano M. Dauerprophylaxe der rezidivierenden „spondylitischen Iridozyklitis” durch Antimalarika und nichtsteroidale Antiphlogistika. Z Rheumatol. 1983; 41 105-106
23 Goel K M, Shanks R QA. Follow-up of 100 cases of juvenile rheumatoid arthritis. Ann Rheum Dis. 1974; 33 25-31
24 Halle F, Prieur A M. Evaluation of methotraxate in the treatment of juvenile chronic arthritis according to the subtype. Clin Exp Rheumatol. 1991; 9 297-302
25 Hemady R K, Baer J C, Foster C S. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin. 1992; 32 241-252
26 Henderly D E, Genstler A J, Smith R E, Rao N A. Changing patterns of uveitis. Am J Ophthalmol. 1987; 103 131-136
27 Horneff G, Forster J, Seyberth H W, Michels H. Empfehlungen der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie zur Therapie mit Etanercept. Monatschr Kinderheilkd. 2001; 149 1066-1069
28 Ilowite N T. Current treatment of juvenile rheumatoid arthritis. Pediatrics. 2002; 109 109-115
29 Kanski J J. Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol. 1977; 95 1794-1797
30 Kanski J J, Shun-Shin G A. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984; 91 1247-1252
31 Kanski J J. Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis. Eye. 1988; 2 641-645
32 Kanski J J. Screening for uveitis in juvenile chronic arthritis. Br J Ophthalmol. 1989; 73 225-228
33 Kanski J J. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990; 34 253-267
34 Kanski J J. Lensectomy for complicated cataract in juvenile chronic iridocyclitis (see comments). Br J Ophthalmol. 1992; 76 72-75
35 Key S N, Kimura S J. Iridocyclitis associated with juvenile rheumatoid arthritis. Am J Ophthalmol. 1975; 80 425-429
36 Kilmartin D J, Forrester J V, Dick A D. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol. 1998; 82 737-742
37 Kimura S J, Hogan M J, Thygeson P. Uveitis in children. Arch Ophthalmol. 1954; 51 80-88
38 Kimura S J, Hogan M J. Uveitis in children: analysis of 264 cases. Trans Am Ophthalmol Soc. 1964; 62 173-192
39 Kiessling U, Doring E, Listing J, Meincke J, Schontube M, Strangfeld A, Zink A. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980 - 88. J Rheumatol. 1998; 25 (9) 1837-1843
40 Kotaniemi K. Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexat. Clin Exp Rheumatol. 1998; 16 469-471
41 Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1999; 17 119-122
42 Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology. 2001; 108 2071-2075
43 Kotaniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritis and comparable conditions. J Rheumatol. 2001b; 28 309-312
44 Koskull S von, Truckenbrodt H, Holle R, Hormann A. Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study. Ann Rheum Dis. 2001; 60 (10) 940-945
45 Lazar M, Weiner M J, Leopold I H. Treatment of uveitis with methotrexate. Am J Ophthalmol. 1969; 67 383-387
46 Leak A M, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis. 1991; 50 653-657
47 Lovell D J, Giannini E H, Reiff A. et al . Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000; 342 763-769
48 Malagon C, Kerckhove C, Giannini E H. et al . The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J Rheumatol. 1992; 19 160-163
49 Michels H. Pharmakotherapie bei rheumatischen Erkrankungen im Kindesalter. Praktische Pädiatrie. 2001; 5 278-288
50 Minden K, Kiessling U, Listing J, Niewerth M, Döring E, Meincke J, Schöntube M, Zink A. Prognosis of patients with juvenile chronic arthritis and juvenile spondylarthropathy. J Rheumatol. 2000; 27 2256-2263
51 Ohno S, Char D H, Kimura S J, O'Connor G R. HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis. Br J Ophthalmol. 1977; 61 59-61
52 Olson N Y, Lindsey C B, Godfrey W A. Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Chil. 1988; 142 1289-1292
53 Paivonsalo-Hietanen T, Tuominen J, Saari K M. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000; 78 84-88
54 Perkins E S. Pattern of uveitis in children. Br J Ophthalmol. 1966; 50 169-185
55 Petty R E, Cassidy J T, Sullivan D B. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr. 1973; 83 386-389
56 Petty R E, Southwood T R, Baum J, Bhettay E, Glass D N, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur A M. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998; 25 (10) 1991-1994
57 Ramadan A, Nussenblatt R. Cytotoxic agents in ocular inflammation. Ophthalmol Clin North Am. 1997; 10 377-387
58 Reiff A, Takei S, Sadeghi S. et al . Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum. 2001; 44 1411-1415
59 Rosenberg A M, Oen K G. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986; 29 797-800
60 Rosenberg A M, Oen K G. The relationsship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986; 29 797-800
61 Rosenberg A M. Uveitis associated with juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1987; 16 158-173
62 Rothova A, Buitenhuis H J, Meenken C. et al . Uveitis and systemic disease. Br J Ophthalmol. 1992; 76 137-141
63 Ruperto N, Levinson J E, Ravelli A, Shear E S, Link Tague B, Murray K, Martini A, Giannini E H. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol. 1997; 24 (5) 945-951
64 Ruperto N, Ravelli A, Levinson J E, Shear E S, Murray K, Link Tague B, Martini A, Glass D N, Giannini E H. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol. 1997; 24 (5) 952-958
65 Samson C M, Waheed N, Baltatzis S, Foster C S. Methotrexate therapy for chronic noninfectious uveitis. Analysis of a case series of 160 patients. Ophthalmology. 2001; 108 1134-1139
66 Sand B B, Krogh E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol. 1991; 69 145-148
67 Savolainen H A, Kautianen H, Isomaki H, Aho K, Verronen P. Azathioprin in patients with juvenile chronic arthritis: a long-term follow-up study. J Rheumatol. 1997; 24 2444-2450
68 Schaller J G, Johnson G D, Holborow E J. et al . The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheumatol. 1974; 17 409-416
69 Schaller J G. Juvenile rheumatoid arthritis: series 1. Arthritis Rheumatol. 1977; 20 165-170
70 Schneider R, Passo M H. Juvenile rheumatoid arthritis. Rheum Dis Clin N Am. 2002; 28 503-530
71 Sherry D D, Mellins E D, Wedgewood R J. Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child. 1991; 145 1026-1028
72 Shetty A K, Zganjar B E, Ellis G S. et al . Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus. 1999; 36 125-128
73 Smiley W K. The visual prognosis in Still's disease with eye involvement. Proc R Soc Med. 1960; 53 196-199
74 Smiley W K. The eye in juvenile rheumatoid arthritis. Trans Ophthalmol Soc UK. 1974; 94 817-829
75 Smith J R, Levinson R D, Holland G N. et al . Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001; 45 252-257
76 Southwood T R, Malleson P N. Antinuclear antibodies and chronic arthritis (JCA): search for a specific autoantibody associated with JCA. Ann Rheum Dis. 1991; 50 595-598
77 Spalter H F. The visual prognosis in juvenile rheumatoid arthritis. Trans Am Ophthalmol Soc. 1975; 73 554-570
78 Speckmaier M, Findeisen J, Woo P. et al . Low-dose methotrexate in systemic onset juvenile chronic arthritis. Clin Exp Rheumatol. 1989; 7 647-650
79 Stoeber E. Prognosis in Juvenile Chronic Arthritis. Eur J Pediatr. 1981; 135 225-228
80 Tugal-Tutkun I, Havrlikova K, Power W J, Foster C S. Changing patterns in uveitis of childhood. Ophthalmology. 1996; 103 375-383
81 Vesterdal E, Sury B. Iridocyclitis and bandshaped corneal opacity in juvenile rheumatoid arthritis. Acta Ophthalmol (Copenh). 1950; 28 321-327
82 Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986; 104 874-851
83 Wallace C A, Bleyer W A, Sherry D D. et al . Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1989; 32 677-681
84 Wallace C A, Levinson J E. Juvenile Rheumatoid Arthritis: Outcome and Treatment for the 1990's. Rheum Disease Clinics of North Am. 1991; 17 891-905
85 Weiss A H, Wallace C A, Sherry D D. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr. 1998; 133 266-268
86 Wolf M D, Lichter P R, Ragsdale C G. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987; 94 1242-1248
87 Young B J, Cunningham W F, Akingkein T. Double-masked, controlled clinical trial of 5 % tolmetin versus 0,5 % prednisolone versus 0,9 % saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol. 1982; 26 389-391
88 Zak M, Pederson F K. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology. 2000; 39 198-204

1 Die Empfehlungen wurden erarbeitet unter Mitwirkung von: Ophthalmologie: M. Becker, A. Heiligenhaus, T. Hudde, U. Pleyer, K.-P. Steuhl, S. Thurau, M. Zierhut. Pädiatrie: S. Benseler, G. Bürk, S. Fahl, D. Föll, M. Frosch, G. Ganser, S. Kastner, I. Kleine, E. Lainka, K. Mönkemöller, J. Ndagijimana, U. Neudorf, T. Niehues, J. Roth, S. Seeliger, N. Wagner, R. Wieland, H. Winowski.

2 Die Empfehlungen wurden erarbeitet unter Mitwirkung von: Ophthalmologie: M. Becker, A. Heiligenhaus, T. Hudde, U. Pleyer, K.-P. Steuhl, S. Thurau, M. Zierhut. Pädiatrie: S. Benseler, G. Bürk, S. Fahl, D. Föll, M. Frosch, G. Ganser, S. Kastner, I. Kleine, E. Lainka, K. Mönkemöller, J. Ndagijimana, U. Neudorf, T. Niehues, J. Roth, S. Seeliger, N. Wagner, R. Wieland, H. Winowski.

Prof. Dr. med. Arnd Heiligenhaus

Augenabteilung am St.-Franziskus-Hospital

Hohernzollernring 74

48145 Münster

Email: arnd.heiligenhaus@t-online.de